Ethyl N-allyl-1-oxo-2,7-naphthyridin-3-carboxylate 12 (60%, for the three steps): 1 HNMR （300 MHz, CDCl 3 ）ppm: 1.39 (t, 3H), 4.37 (m, 2H), 5.11 (m, 4H), 5.80 (m, 1H), 6.99 (s, 1H), 7.39 (d, 1H), 7.77 (d, 1H), 9.62 (s, 1H).
Synthesis of 2,7-Naphthyridine-Containing Analogs of

General Procedure for preparation of cyclization precursors 13,16
Preparation of 12: To a suspension of ethyl 1-oxo-2,7-naphthyridin-3-carboxylate 11 16 (100 mg, 0.46 mmol) in a mixture of water (0.03 mL) and toluene (10 mL), was successively added potassium carbonate (127mg, 0.92mmol), lithium bromide (96 mg, 0.92 mmol), TBAB (16 mg, 0.05 mmol) and allyl bromide or propargyl bromide (1.46 mmol in toluene). The reaction mixture was then heated at 60℃ for 4h. The inorganic residues were removed by filtration over a pad of Celite, and washed thoroughly with dichloromethane. The filtrate was concentrated under reduced pressure. The residue was purified by flash chromatography (Ethyl acetate : Petroleum ether = 1.5:1) to give 12 as a yellow liquid.
Preparation of 13 or 16:
To a solution of 12 (0.31mmol) in THF (3mL) and water (1mL) was added lithium hydroxide monohydrate (20 mg, 0.47 mmol) at 0℃. After being stirred at the same temperature for 10 min, the solvents were removed in vacuo and the residue was re-dissolved into water (5mL). The solution was adjusted to pH 2-3 by addition of 1N HCl. The suspension was concentrated in vacuo, giving crude product which was used directly for next step.
The crude acid prepared as above was suspended in dichloromethane. Oxalyl dichloride (0.5 ml) was dropped into the solution. The mixture was refluxed for 2 h (suspension), and then concentrated in vacuo. To the residue, 10ml dichloromethane was added (still suspension). The mixture was cooled to 0 °C over a cryohydrate bath. Aniline (116 mg, 1.24 mmol) and sodium dicarbonate (100 mg) were added into the reaction mixture. The suspension solution was stirred at 0 °C for 20 min, and then at room temperature for 10 min. The mixture was filtered. The filtrate was concentrated to 1/4 volume which was loaded onto the silica-gel column, eluted using CH 2 Cl 2 /CH 3 OH = 25:1 to afford amide 13 or 16 as off-white product. 
General Procedure for the intramolecular aza-Diels-Alder cyclization: To a solution of
Ph 3 PO (837 mg, 2.98 mmol) in anhydrous CH 2 Cl 2 (20 mL) at 0°C, was added dropwise a solution of Tf 2 O (0.25 mL, 1.5 mmol). After the mixture was stirred for 15 min at 0°C, a solution of 2-allyl-1-oxo-N-aryl-2,7-naphthyridin-3-carboxamide 13 (1.0 mmol) or 2-propargyl-1-oxo-N-aryl-2,7-naphthyridin-3-carboxamide 16 (1.0 mmol) in CH 2 Cl 2 (20 mL) was dropped slowly. The reaction was stirred at 0 °C for 0.5 h, and then at rt for 1-5h. The completion of the reaction was detected by disappearance of the carboxamide substrate 13. A solution of aqueous Na 2 CO 3 (10%, 10 mL) was added to quench the reaction. The mixture was extracted with CHCl 3 (3x30 mL). The organic phase was combined, washed with brine and dried over anhydrous Na 2 SO 4 . After filtration, the solvent was removed, and the residue was subjected to column chromatography (CH 2 Cl 2 /CH 3 OH = 10:1). The cyclization products 7a-7c were obtained. 
